Vicente, EC, Pease, S, Imran, N, Gandhi, K, Ait-Tihuaty, M, Turkoz, I, Coteur, G, Gary, C, Choudhry, Z, Ramchandran, S, Vissing, J. Assessment of patient-reported outcomes from the phase 3 vivacity-MG3 study of nipocalimab in gMG. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Villaverde, R, Gomez-Ballesteros, R, Reyes, V, Armangue, T, Querol, L, Gutierrez-Gutierrez, G, Sotoca, J, Ares, A, Salas, E, Abos, PD, Squaglia, A, Maurino, J, Cortes-Vicente, E. Herding-like behaviour in myasthenia gravis treatment decisions: exploring underlying mechanisms. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Lewis, RA, Suresh, N, Mazzeo, A, Allen, JA, Querol, L, Hussain, YM, Gwathmey, KG, Guptill, JT, Istas, G, Van Hoorick, B, Mole, T, Kuwabara, S, Basta, I, van Door, PA. SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: SELECTED SECONDARY OUTCOMES FROM THE ADHERE TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Lewis, RA, Querol, L, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Lu, Y, Alonso, MA, Atassi, N, Hughes, RAC. EFFICACY OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: PHASE 2 SUBGROUP ANALYSES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Falzone, Y, Querol, L, Lewis, R, Hartung, HP, van Doorn, P, Lin, J, Donnie, A, Attarian, S, Wallstroem, E, Auwarter, K, Lu, Y, Alonso, MA, Atassi, N, Hughes, R. SAFETY AND EFFICACY OF RILIPRUBART IN CIDP 76-WEEK PHASE 2 TRIAL RESULTS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

De Lorenzo, A, Moretti, GS, Bertini, A, De Lorenzo, A, Vidiella, RC, Falzone, YM, Fortanier, E, Gendre, T, Gentile, F, Hadden, R, Islam, B, Kleopa, K, Cejas, LL, Leonardi, L, Mandia, D, Marion, M, Mira, V, Peric, S, Querol, L, Rajabally, Y, Sevilla, T, Tomaselli, PJ, Tozza, S, Bosca, M, Brouwer, M, Cocco, A, Cousyn, L, De Santis, T, Gonzalez, F, Lukic, MJ, Mistry, N, Maranzano, A, Morena, E, Nakano, FN, Saura, GO, Sechi, E, Ticozzi, N, Troisi, S, Tsokkos, T, Aymeric, W, Pisciotta, C, Orazio, EN, Pareyson, D, Doneddu, PE. CHAT-GPT-4O IN DIAGNOSIS AND MANAGEMENT OF REAL-LIFE POLYNEUROPATHY CASES: COMPARATIVE ANALYSIS WITH NEUROLOGISTS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Gallo, C, Doneddu, PE, Collet-Vidiella, R, Cocito, D, Manganelli, F, Falzone, Y, Pinter, GL, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Dalla Bella, E, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. EFFECT OF RITUXIMAB ON NEUROFILAMENT IN CIDP: DATA FROM THE CIDPRIT RANDOMIZED CONTROLLED TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Allen, JA, Door, PAV, Benedetti, L, Basta, I, Dysgaard, T, Eggers, C, Guptill, JT, Gwathmey, KG, Hewamadduma, C, Hofman, E, Hussain, YM, Kuwabara, S, Le Masson, G, Leypoldt, F, Lin, J, Lipowska, M, Lowe, M, Pinter, GL, Querol, L, Simu, MA, Chang, TN, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA. EFFICACY AND SAFETY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Storm, CS, Kia, DA, Almramhi, MM, Bandres-Ciga, S, Finan, C, Hingorani, AD, Wood, NW, Clarimón, J., Dols-Icardo O., Kulisevsky J., Marín J., Pagonabarraga J., Lynch, Timothy L.. Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome. Nature Communications. 2021; 12(1)DOI:10.1038/s41467-021-26280-1. PMID:34930919. IF:17.694(Q1/1D).

Blauwendraat, C, Iwaki, H, Makarious, MB, Bandres-Ciga, S, Leonard, HL, Grenn, FP, Lake, J, Krohn, L, Tan, M, Kim, JJ, Gibbs, JR, Hernandez, DG, Ruskey, JA, Pihlstrom, L, Toft, M, van Hilten, JJ, Marinus, J, Schulte, C, Brockmann, K, Sharma, M, Siitonen, A, Majamaa, K, Eerola-Rautio, J, Tienari, PJ, Grosset, DG, Lesage, S, Corvol, JC, Brice, A, Wood, N, Hardy, J, Gan-Or, Z, Heutink, P, Gasser, T, Morris, HR, Noyce, AJ, Nalls, MA, Singleton, AB, Clarimón J., Dols-Icardo, O, Kulisevsky J., Pagonabarraga, J, Int Parkinsons Dis Genomics Consor. Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease. ANNALS OF NEUROLOGY. 2021; 90(1)DOI:10.1002/ana.26090. PMID:33901317. IF:11.274(Q1/1D).

Aibar-Durán JÁ, Villalba Martínez G, Freixer-Palau B, Araus-Galdós E, Morollón Sanchez-Mateos N, Belvis Nieto R, Revuelta Rizo M, Molet Teixeido J, García Sánchez C, de Quintana Schmidt C, Muñoz Hernandez F, Rodríguez Rodríguez R. Long-Term Results of Cortical Motor Stimulation for Neuropathic Peripheral and Central Pain: Real-World Evidence From Two Independent Centers.. Neurosurgery. 2024; 94(1)DOI:10.1227/neu.0000000000002638. PMID:37638720. IF:3.900(Q1/1D).

Kulisevsky J, Esquivel A, Freire-Álvarez E, Gómez-Esteban JC, Legarda-Ramírez I, Mata-Álvarez-Santullano M. SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.. REVISTA DE NEUROLOGIA. 2023; 77(s02)DOI:10.33588/rn.77s02.2023217. PMID:37752685. IF:0.800(Q4/9D).

Sampedro F. The success of assessing cortical microstructure through surface-based diffusion-weighted neuroimaging.. CLINICAL NEUROLOGY AND NEUROSURGERY. 2023; 234DOI:10.1016/j.clineuro.2023.107990. PMID:37806052. IF:1.800(Q2/5D).

Pérez-González, R, Vázquez-Oliver, A, Rivas-Asensio, E, Campolongo, A, Pons-Pons, G, Martínez-Horta, S, Pagonabarraga, J, Pascual-Sedano, B, Kulisevsky, J. Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood. PARKINSONISM & RELATED DISORDERS. 2026; 144DOI:10.1016/j.parkreldis.2026.108208. PMID:41643584. IF:3.400(Q2/3D).

Puig-Davi, A, Moreu-Valls, A, Aracil-Bolaños, I, Fernandez-Cocaño, A, Rodríguez-Antigüedad, J, Kulisevsky, G, Horta-Barba, A, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson's disease mild cognitive impairment: a randomized clinical trial. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-31833-1. PMID:41582160. IF:3.900(Q1/2D).

Bernardi, E, López-Lombardía, O, Olmedo-Saura, G, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(2)DOI:10.3390/ijms27020881. PMID:41596528. IF:4.900(Q1/3D).

Ferreira, JJ, Stocchi, F, Antonini, A, Rascol, O, Ebersbach, G, Kulisevsky, J, Fonseca, MM, Ramos, D, Rocha, JF, Brigas, HC, Holenz, J, Poewe, W. Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1715748. PMID:41473225. IF:2.800(Q2/5D).

Camacho-Meño, L, Labandeira, CM, Bravo, SB, Torres, MV, Bejr-Kasem, H, Molina-Crespo, A, Atienza, M, Lanciego, JL, Cantero, JL, Kulisevsky, J, Labandeira-Garcia, JL, Rodriguez-Perez, AI. Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson's disease patients. npj Parkinsons Disease. 2025; 12(1)DOI:10.1038/s41531-025-01230-6. PMID:41366251. IF:8.200(Q1/1D).

Kulisevsky, J, García-Ruíz, P, Outeiro, TF, Gurevich, T, Klivènyi, P, Van Laar, T, Milanov, I, Pirker, W, Popescu, BO, Toft, M, Szász, JA. Pharmacogenetics in advanced Parkinson's disease. JOURNAL OF NEURAL TRANSMISSION. 2025; 132(11)DOI:10.1007/s00702-025-03057-0. PMID:41222708. IF:4.000(Q1/2D).

Garcia-Forn, M, Castany-Pladevall, C, Creus-Muncunill, J, Golbano, A, Escaramís, G, Pérez-Pérez, J, Balantzategi, U, Hernan-Godoy, M, Brito, V, Kulisevsky, J, Martí, E, Pérez-Navarro, E. Sertraline treatment prevents motor dysfunction in a Huntington's disease mouse model and functional decline in patients. Neurotherapeutics. 2025; 22(6)DOI:10.1016/j.neurot.2025.e00716. PMID:40774881. IF:6.900(Q1/1D).

García-González, P, Lara, HR, Compta, Y, Fernandez, M, van der Lee, SJ, de Rojas, I, Saiz, L, Painous, C, Camara, A, Muñoz, E, Marti, MJ, Valldeoriola, F, Puerta, R, Illán-Gala, I, Pagonabarraga, J, Dols-Icardo, O, Kulisevsky, J, Fortea, J, Lleó, A, Olivé, C, de Boer, SCM, Hulsman, M, Pijnenburg, YAL, Belloso, RD, Muñoz-Delgado, L, Rueda, DB, Gómez-Garre, P, Aldecoa, I, Aragonés, G, Vara, JH, Mendioroz, M, Pérez-Tur, J, Visser, PJ, den Braber, A, Papma, JM, Montes, AM, Rodriguez-Rodriguez, E, Blázquez-Folch, J, Miguel, A, García-Gutiérrez, F, Cano, A, Valero, S, Marquié, M, Capdevila-Bayo, M, Rosende-Roca, M, Quintela, I, Carracedo, A, Tàrraga, L, Real, LM, Royo, JL, Erro, ME, Guerrero, C, Torres, DC, Blázquez-Estrada, M, San Millán, B, Teijeira, S, Rolan, DV, Hernández, I, Sánchez-Soblechero, A, de la Casa-Fages, B, López, SS, Baviera-Muñoz, R, Lavín, A, Taipa, R, Amer, G, Martinez-Saez, E, Fernández-Matarrubia, M, Lage-Martínez, C, Alvarez, V, Molina-Porcel, L, Holstege, H, Mir, P, Belbin, O, Boada, M, Fernández, V, Bullido, MJ, Rábano, A, Sánchez-Juan, P, Ruiz, A. A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC. EUROPEAN JOURNAL OF HUMAN GENETICS. 2025; 33(7)DOI:10.1038/s41431-025-01872-3. PMID:40379966. IF:4.600(Q1/2D).

Alberti-Vall, B, Olmedo-Saura, G, Domine, M, Borrell-Pichot, M, Avila, MC, Jordana, AV, Pagonabarraga-Mora, J, Kulisevsky, J, Perez, P. Clinical spectrum of anti-IgLON5 disease: A case series with three distinct movement disorder phenotypes. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Toscano-Prat, C, García-Sánchez, C, Ros-Castelló, V, Barguilla-Arribas, A, Saladich, IG, Rodríguez-Clifford, K, Torra-Balcells, R, Boronat, S, Sierra-Marcos, A. Cognitive and neuro-psychiatric profile in adult patients with epilepsy secondary to Tuberous Sclerosis Complex. EPILEPSY & BEHAVIOR. 2025; 166DOI:10.1016/j.yebeh.2025.110380. PMID:40101321. IF:2.300(Q2/4D).

Rodríguez-Antigüeedad, J, Martínez-Horta, S, Puig-Davi, A, Horta-Barba, A, Pagonabarraga, J, Fonticoba, TD, Jesus, S, Cosgaya, M, Caldentey, JG, Avila-Rivera, MA, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Mayordomo, VG, Ardura, JG, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Pareés, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón, I, Martínez, JR, Buongiorno, MT, Ordas, C, Valero, C, Puente, V, Kurtis, M, Estrada, MB, Martínez-Martín, P, Mir, P, Santos-García, D, Kulisevsky, J. Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline (vol 272, 246, 2025). JOURNAL OF NEUROLOGY. 2025; 272(5)DOI:10.1007/s00415-025-13077-1. PMID:40285930. IF:4.600(Q1/2D).

Rodríguez-Antigüedad, J, Martinez-Horta, S, Puig-Davi, A, Horta-Barba, A, Pagonabarraga, J, Fonticoba, TD, Jesús, S, Cosgaya, M, Caldentey, JG, avila-Rivera, MA, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Mayordomo, VG, Ardura, JG, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Parees, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Martinez, JR, Buongiorno, MT, Ordas, C, Valero, C, Puente, V, Kurtis, M, Estrada, MB, Martínez-Martín, P, Mir, P, Santos-García, D, Kulisevsky, J. Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline. JOURNAL OF NEUROLOGY. 2025; 272(3)DOI:10.1007/s00415-024-12808-0. PMID:40042541. IF:4.600(Q1/2D).

Kordikowski, R, Coutinho, J, Martínez-Martel, I, Penas, C, Martín-Mur, B, Pérez, B, Jiménez-Altayó, F, Pol, O. Pain Hypersensitivity in a Mouse Model of Marfan Syndrome. Antioxidants. 2026; 15(1)DOI:10.3390/antiox15010080. PMID:41596139. IF:6.600(Q1/1D).

Tort, NA, Negrini-Ferrari, SE, Pol, O. Hydrogen-Rich Water Potentiates Cannabinoid- and Gabapentinoid-Induced Analgesia in Neuropathic Pain. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(24)DOI:10.3390/ijms262412155. PMID:41465581. IF:4.900(Q1/3D).

Leganes, C, Zapata, MJM, Valle, JM, Membrilla, E, Bordon, EA, Palazón, P, Fortes, LM, Núñez, B, Alvarez, N, Pueyo, C, Soria, A, Oviedo, M, Delgado-Espinoza, CE, Antonijoan, RM. Fast-track strategy to shorten hospital stay in acute complicated paediatric appendicitis: protocol of the FTAA clinical trial. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

Delgado-Espinoza, CE, Garcia, CP, Hosey, KA, Pestana, MJC, Lasso, LFC, Arbos, RMA. Non-commercial sponsored clinical trials with medicinal products in Spain since CTIS implementation. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

Pontes, C, Cortes, M, Delgado, CE, Castillo, LF, Amaro, K, Torres, F, Antonijoan, RM. Environmental impact of avoidable tertiary care: earth-caring arguments for decentralizing trials. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

Pestana, MC, Lasso, LFC, Hosey, KCA, Espinoza, CED, Garcia, CP, Arbos, RMA. Needle in the haystack: searching for relevance in systematic screening of adverse drug reactions. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

Pontes, C, Cortés, M, de Pando, T, Gomez-Oliveros, B, Antonijoan, RM, Carot-Sans, G, Ramiro, M. Increasing use of gabapentinoids out of their authorised indications. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

Navarro, TDP, Perez, AM, Carot-Sans, G, Martinez, LE, Belis, MV, Nadal, AM, Garcia, CP. Rising alarm on strong opioids in the elderly: a description of utilization and prescription characteristics. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).

Bernardo, M, Amoretti, S, Cuesta, MJ, Parellada, M, Mezquida, G, Corripio I., Mico, Juan Antonio. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2021; 14(3)DOI:10.1016/j.rpsm.2020.07.004. PMID:33020032. IF:6.795(Q1/3D).

Cardoner N, Andero R, Cano M, Marin-Blasco I, Porta-Casteràs D, Serra-Blasco M, Via E, Vicent-Gil M, Portella M. Impact of Stress on Brain Morphology: Insights into Structural Biomarkers of Stress-related Disorders.. Current Neuropharmacology. 2024; 22(5)DOI:10.2174/1570159X21666230703091435. PMID:37403395. IF:5.300(Q1/2D).

Gawron, LP, Portella, MJ, Pousa, E. Insight and depressive symptoms in eating disorders: the mediating role of disorder-specific psychopathology. PSYCHIATRY RESEARCH. 2026; 358DOI:10.1016/j.psychres.2026.116965. PMID:41610566. IF:3.900(Q1/2D).

Carmona-Rocha, E, De Diego-Adeliño, J, Tribó, MJ, Puig, L. Psychotropic Drugs: A Practical Guide for Use in Dermatology. Actas Dermo-Sifiliograficas. 2026; 117(2)DOI:10.1016/j.ad.2025.104518. PMID:41352592. IF:(Q/D).

Hamina, A, Pinzón-Espinosa, J, Taipale, H, Schneider-Thoma, J, Radua, J, Efthimiou, O, Cardoner, N, Correll, CU, Fusar-Poli, P, Mittendorfer-Rutz, E, Penninx, BWJH, Ruhe, HG, Tanskanen, A, Vinkers, CH, Leucht, S, Vieta, E, Cipriani, A, Tiihonen, J, Luykx, JJ. Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register-based study. World Psychiatry. 2026; 25(1)DOI:10.1002/wps.70013. PMID:41536102. IF:65.800(Q1/1D).

Julià, A, Jaén, I, Giménez, MC, García-Palacios, A, Pascual, JC, Estévez, AS, Lara, A, Méndez, I, Romero, S, Puntí, J, Soler, J, Solé-Casals, J, López-Solà, M, Vega, D. A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial. Jmir Research Protocols. 2026; 15DOI:10.2196/86413. PMID:41592792. IF:(Q/D).

Massons, C, Cobo, J, Navarra-Ventura, G, Vicent-Gil, M, Serra-Blasco, M, Jubert, A, Agut, M, Palao, DJ, Cardoner, N. Exploring the nexus of cognition and insight in euthymic bipolar patients. EUROPEAN JOURNAL OF PSYCHIATRY. 2026; 40(1)DOI:10.1016/j.ejpsy.2025.100336. PMID:. IF:1.500(Q3/7D).